<DOC>
	<DOCNO>NCT01717404</DOCNO>
	<brief_summary>To understand Mexiletine restore normal colonic motility patient irritable bowel syndrome - constipation ( IBS-C ) genetic mutation SCN5A .</brief_summary>
	<brief_title>Effects Mexiletine Colonic Transit Patient With Irritable Bowel Syndrome - Constipation ( IBS-C )</brief_title>
	<detailed_description>To understand Mexiletine restore normal colonic motility patient missense mutation SCN5A , encode voltage-sensitive sodium channel NaV1.5 know rescue certain expression defect NaV1.5 vitro .</detailed_description>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Mexiletine</mesh_term>
	<criteria>Established IBS diagnosis know A997T mutation NaV1.5T Normal 48hour baseline transit study Current use mexiletine Inability stay Rochester 9 day test Known allergy mexiletine Inability complete daily diary Taking medication know affect myotonia , coexist neuromuscular disease , another serious medical illness include second thirddegree heart block , atrial flutter , atrial fibrillation , ventricular arrhythmia , history cardiac arrhythmia require medication , congestive heart failure , symptomatic cardiomyopathy , symptomatic coronary artery disease Inability withdraw medication know interact mexiletine . Patient currently medication</criteria>
	<gender>Female</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>IBS</keyword>
</DOC>